Essence Securities maintains Medicilon's buy rating: rapid improvement in service capabilities, sustained high growth in 2022Q1 performance

Post date April 30, 2022 — 12:38 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

Don't be afraid of fluctuations! The April list of the 2nd "Jinhua Cai Cup" Private Equity Competition of West China Securities was released

May 20, 2022 — 18:00

Asia Potash International: There is no exchange gain or loss problem

May 20, 2022 — 17:57

Kangtai Medical: The company's decline in sales of blood oxygen products in 2021 is mainly affected by changes in demand and the high base of the previous year

May 20, 2022 — 17:56

TANSUN: The company's business is stable, the orders on hand are sufficient, and the number of employees has maintained an increasing trend compared with the beginning of the year

May 20, 2022 — 17:55

Desheng Technology: 002908 Desheng Technology Performance Briefing Session, Roadshow Activity Information 20220520- CFi.CN Zhongcai Network

May 20, 2022 — 17:46

The dividend of the epidemic subsided, and the stable medical 752 million cross-border injection and puncture track-News Channel-Hexun.com

May 20, 2022 — 17:40

Bank of China Zhong Hong: Central Bank Digital Currency New Trends in Global Competition and Cooperation Bank Channel Hexun Network

May 20, 2022 — 17:00

Experimental monkey trapped in time-Titanium Media Official Website

May 20, 2022 — 16:55

"I don't think it's unusual for a monkey to rise to 200,000"

May 20, 2022 — 16:55

Home » News » Essence Securities maintains Medicilon's buy rating: rapid improvement in service capabilities, sustained high growth in 2022Q1 performance